Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	0.08	0.27	0.17	0	0.03	0.81
Cash & Short-Term Investments	0.08	0.27	0.17	0	0.03	0.81
Cash Growth	-88.15%	61.30%	7840.96%	-93.39%	-96.12%	27300.30%
Accounts Receivable	0.17	0.13	0.05	0.04	0.02	0.04
Inventory	0.14	0.05	0.07	0.01	0.01	0.01
Other Current Assets	0.03	0.15	0.07	0.04	0.09	0.02
Total Current Assets	0.41	0.6	0.36	0.09	0.16	0.89
Net Property, Plant & Equipment	0	0	0	0.01	0.01	0.03
Other Long-Term Assets	2.53	2.51	2.24	2.07	1.93	1.65
Total Assets	2.95	3.11	2.6	2.16	2.1	2.57
Accounts Payable	2.2	1.72	1.93	0.67	0.59	0.58
Short-Term Debt	0.04	-	-	-	-	-
Current Portion of Leases	-	-	-	-	-	0.02
Other Current Liabilities	0.04	0.1	0.17	-	-	0.02
Total Current Liabilities	2.29	1.81	2.09	0.67	0.59	0.62
Long-Term Debt	-	0.04	0.04	0.04	0.03	0.03
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	0.01
Total Long-Term Liabilities	-	0.04	0.05	0.05	0.04	0.04
Total Liabilities	2.29	1.85	2.15	0.73	0.63	0.66
Common Stock	12.64	12.64	9.14	8.69	7.55	6.33
Additional Paid-in Capital	3	2.96	2.13	1.86	1.64	1.55
Accumulated Other Comprehensive Income	0.01	0.02	0.02	0.01	-	-
Retained Earnings	-15	-14.37	-10.84	-9.13	-7.73	-5.97
Shareholders' Equity	0.66	1.25	0.45	1.44	1.46	1.91
Total Liabilities & Equity	2.95	3.11	2.6	2.16	2.1	2.57
Total Debt	0.04	0.04	0.04	0.04	0.03	0.04
Net Cash (Debt)	0.04	0.23	0.13	-0.04	0.01	0.77
Net Cash Growth	-84.27%	80.82%	-	-	-99.22%	-
Net Cash Per Share	-	0.00	0.00	-	-	0.01
Book Value	0.66	1.25	0.45	1.44	1.46	1.91
Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02
Tangible Book Value	0.66	1.25	0.45	1.44	1.46	1.91
Tangible Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02

Updated Apr 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.